NewAmsterdam Pharma Company NV (NAMS) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.93
-0.68
-0.43
-0.18

Details

Expected EPS
-0.491965
Actual EPS
-0.340383
Surprise EPS
0.15
Surprise Percent
+30.81%

Description

⁨NewAmsterdam Pharma Company NV⁩ (⁦NAMS⁩) has reported earnings of ⁦-0.340383⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts